Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
14 School House Road , Franklin Township, NJ, 08873, US
Catalent is the global leader in enabling pharmaceutical, biotechnology, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients globally. With broad scale and deep expertise, Catalent is a preferred partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.
When a biologic drug is being studied in a clinical trial, the sponsor may want to compare the investigational product to a current standard of care, known as a comparator drug. In other cases, a co-medication may need to be dosed along with the study drug. Sourcing commercially available branded biologics can be challenging for […]
Released By Catalent Pharma Solutions
Along with a discussion, examples of real-life tactical and operational decisions involved in the integrated approach to drug development will be presented.
What are some key supply considerations that sponsors need to keep in mind when planning a DCT? What should they look out for when choosing a supply partner?
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.
As the cell and gene therapy market continues to grow, analytical science will play an increasingly important role.
This ebook analyzes how to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.
The oral solid dose market is robust due to demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery vehicles.
The constant drive for efficiency has become an essential element of any business process, across all industries.
Cell and gene therapies represent the next-generation of therapeutics.
The Importance of Risk Assessment and the Role of Evaluating Elemental Impurities
Analytical technology and processes are evolving as the biologics industry continues to grow.
As the biologics market grows, the demand increases for development and manufacturing capabilities.
Will be capable of producing more than 40 different radioisotopes.
By: Charlie Sternberg
The new 375,000-square-foot carbon-neutral site is capable of producing at least 40 million laboratory pipette tips per week.
Will enable the company to manufacture the vast majority of its advanced medicines in the U.S.
Tocilizumab is a targeted immunomodulatory monoclonal antibody directed against the interleukin-6 receptor, indicated to treat multiple inflammatory and autoimmune disorders.
By: Rachel Klemovitch
New collaboration aims to accelerate the development of AAHI’s vaccine candidates.
Anthony has served as the global leader for Parexel Biotech since its inception in 2019, and most recently as President and Global Head, Parexel Biotech.
The investment provides NewAmsterdam Pharma with commercial capacity for a fixed-dose combination of obicetrapib and ezetimibe to meet potential commercial demand.
Approval is based on comprehensive analytical, non-clinical, and clinical similarity data.
The acquisition complements Kite's expertise in cell therapy by incorporating Interius' integrating in vivo platform.
Integrates Schreiner MediPharm’s Robust RFID-Labels with Bluesight’s KitCheck Scanning Stations to enable precise tracking of medications.
Ranks in the 96th percentile and among the top 5% of companies evaluated globally for sustainability.
Spring Bio to offer LSPedia's OneScan to global pharma manufacturers.
Jazz obtains exclusive worldwide rights to develop and commercialize preclinical asset SAN2355 in epilepsy and other potential indications.
Hahn joins Nucleus RadioPharma after serving as CEO-partner of Flagship Pioneering and CEO of Harbinger Health since 2021.
Wegovy is now positioned as the first and only GLP-1 treatment.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
